1. Academic Validation
  2. CDC42 regulates PYRIN inflammasome assembly

CDC42 regulates PYRIN inflammasome assembly

  • Cell Rep. 2022 Nov 15;41(7):111636. doi: 10.1016/j.celrep.2022.111636.
Lotte Spel 1 Lea Zaffalon 1 Cyrielle Hou 1 Nicaise Nganko 1 Chloé Chapuis 1 Fabio Martinon 2
Affiliations

Affiliations

  • 1 Department of Immunobiology, University of Lausanne, 155 Ch. des Boveresses, 1066 Epalinges, Switzerland.
  • 2 Department of Immunobiology, University of Lausanne, 155 Ch. des Boveresses, 1066 Epalinges, Switzerland. Electronic address: fabio.martinon@unil.ch.
Abstract

The PYRIN inflammasome pathway is part of the innate immune response against invading pathogens. Unprovoked continuous activation of the PYRIN inflammasome drives autoinflammation and underlies several autoinflammatory diseases, including familial Mediterranean fever (FMF) syndrome. PYRIN inflammasome formation requires PYRIN dephosphorylation and oligomerization by molecular mechanisms that are poorly understood. Here, we use a functional genetics approach to find regulators of PYRIN inflammasome function. We identify the small Rho GTPase CDC42 to be essential for PYRIN activity and oligomerization of the inflammasome complex. While CDC42 catalytic activity enhances PYRIN phosphorylation, thereby inhibiting it, the inflammasome-supportive role of CDC42 is independent of its GDP/GTP binding or hydrolysis capacity and does not affect PYRIN dephosphorylation. These findings identify the dual role of CDC42 as a regulator of PYRIN and as a critical player required for PYRIN inflammasome assembly in health and disease.

Keywords

CDC42; CP: Immunology; FMF; MEFV; NOCARH; PAAND; PYRIN; RhoA; inflammasome; small GTPase.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-15663
    99.43%, PAK Inhibitor
    PAK